Follow this preprint

Angiotensin converting enzyme inhibitors and risk of lung cancer: a population-based cohort study

Joshua Kai Fung Hung, Jiandong Zhou, Sharen Lee, Yunlong Xia, Ying Liu, Yuhui Zhang, Wing Tak Wong, Guangling Li, Tong Liu, Bernard Man Yung Cheung, Ian Chi Kei Wong, Qingpeng Zhang, Gary Tse
doi: https://doi.org/10.1101/2021.01.04.21249217
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2021.01.04.21249217
History 
  • January 6, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Joshua Kai Fung Hung*,1,
  2. Jiandong Zhou*,2,
  3. Sharen Lee1,
  4. Yunlong Xia, MD PhD FESC3,
  5. Ying Liu, MD PhD3,
  6. Yuhui Zhang, MD PhD4,
  7. Wing Tak Wong, PhD5,
  8. Guangling Li, MD PhD6,
  9. Tong Liu, MD PhD6,
  10. Bernard Man Yung Cheung, PhD FRCP7,
  11. Ian Chi Kei Wong, PhD8,
  12. Qingpeng Zhang, PhD#,2 and
  13. Gary Tse, PhD FRCP FFPH#,6
  1. 1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
  2. 2School of Data Science, City University of Hong Kong, Hong Kong, China
  3. 3Department of Cardiovascular Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, China
  4. 4Fuwai Hospital of Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing, China
  5. 5School of Life Sciences, Chinese University of Hong Kong, Hong Kong, China
  6. 6Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
  7. 7Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, Hong Kong, China
  8. 8Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
  1. ↵#Corresponding authors
    Qingpeng Zhang, PhD, School of Data Science, City University of Hong Kong, Hong Kong, China Email: qingpeng.zhang{at}cityu.edu.hk, Gary Tse, PhD, FRCP, FFPH, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China, Email: gary.tse{at}doctors.org.uk
Back to top
Posted January 06, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Email
Angiotensin converting enzyme inhibitors and risk of lung cancer: a population-based cohort study
Joshua Kai Fung Hung, Jiandong Zhou, Sharen Lee, Yunlong Xia, Ying Liu, Yuhui Zhang, Wing Tak Wong, Guangling Li, Tong Liu, Bernard Man Yung Cheung, Ian Chi Kei Wong, Qingpeng Zhang, Gary Tse
medRxiv 2021.01.04.21249217; doi: https://doi.org/10.1101/2021.01.04.21249217
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.